The adoption of cold pain therapy products is rising across the globe due to the growing adoption of analgesic patches, increasing aging population, growing use of cold pain therapy among middle-aged women, and the rising preference for self-care. However, a lack of reimbursement for cold pain therapy, absence of clinical evidence in the favor of cold pain therapy, and significant health hazards and discomfort related to cold pain therapy products are restraining the growth of this market.
Complete report on global cold pain therapy market spread across 168 pages, profiling 20 companies and supported with 133 tables and 43 figures is now available at http://www.reportsnreports.com/reports/718464-cold-pain-therapy-market-by-product-otc-pharmaceuticals-gel-cream-patch-spray-medical-devices-wraps-ice-pack-prescription-non-motorized-devices-application-musculoskeletal-disorders-sport-medicin-st-to-2021.html .
The global cold pain therapy market has been segmented on the basis of products into OTC [pharmaceuticals (gels, ointments, and creams, sprays and foams, patches, and roll-ons) and medical devices (cold packs, cooling towels, compress, wraps, and pads)] and prescription-based devices (motorized and non-motorized devices); application (musculoskeletal disorders, sport medicine, post-operative, post-trauma, and physical therapy); and region (North America, Europe, Asia-Pacific, and the Rest of the World).
The musculoskeletal disorders application segment is expected to account for the largest market share in 2016 and projected to grow at the fastest CAGR during the study period. The availability of a large number of OTC pain management products for musculoskeletal disorders, instant pain relief provided by cold therapy products, and increasing trend of self-care are some factors driving the growth of the musculoskeletal disorders market.
In 2015, the global market was dominated by Hisamitsu Pharmaceutical Co., Inc. (Japan), 3M Company (U.S.) and Breg Inc. (U.S.). New product launches, agreements and contracts, and mergers are the major strategies adopted by market players to strengthen their presence and increase their share in the cold pain therapy market.
Get a corporate level discount on a copy of Cold Pain Therapy Market by Product (OTC (Pharmaceuticals - Gel, Cream, Patch, Spray) (Medical Devices - Wraps, Ice Pack), Prescription (Non-Motorized Devices)), Application (Musculoskeletal Disorders, Sport Medicine, Physical Therapy) - Forecast to 2021 research report at http://www.reportsnreports.com/contacts/discount.aspx?name=718464 .
Geographically, North America is expected to command the largest share of the global cold pain therapy market in 2016, followed by Europe. The growth in the North American market is primarily driven by various factors, including the large number of surgeries, stringent regulations on opioid prescription, and new product launches.
On a related note, another research on Plasma Therapy Market Global Forecast to 2021 says, the market is expected to grow from USD 135.6 million in 2016 to USD 297.6 million by 2021, at a CAGR of 14.0% from 2016 to 2021. The antilogous source segment is estimated to account for the largest share of the plasma therapy market in 2016. The hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy market in 2016. Companies like BioLife Plasma Services, Cambryn Biologics LLC, Biotest, CSL Ltd., Grifols International S.A., Kedrion S.p.A., LFB, Bio Products Laboratory Ltd., China Biologic Products, Inc. and Octapharma have been profiled in this 210 pages research report available at http://www.reportsnreports.com/reports/634202-plasma-therapy-market-by-type-pure-prp-leukocyte-rich-prp-pure-platelet-rich-fibrin-leukocyte-rich-fibrin-source-autologous-allogenic-application-orthopedic-dermatology-cardiac-muscle-injury-end-user-region-global-forecast-to-2021.html .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Name: Ritesh Tiwari
Email: Send Email
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
Release ID: 139344